A supplier of highly doped fibers designs, manufactures and markets high performance fibers as well as fiber components and subassemblies (optical engines) for fiber amplifiers and lasers using its unique and proprietary Direct Nanoparticle Deposition (DND) technology.
A cell culture/biotech company making strides in enhancing organ preservation and cell culturing at both room temperature and through cryopreservation. The LIFOR® technology is the nanoparticle component of the solution, which carries the oxygen or any type of drug or nutrient that the developers wish to place into the nanoparticle.
LightSmyth develops innovative nanophotonic products. Target areas include integrated photonics, free-space diffractives, and consumer products. LightSmyth products and innovations are centered around application of holographic and diffractive principles combined with manufacturing via state-of-the-art semiconductor patterning tools such as Deep UltraViolet (DUV) steppers/scanners.
The company is developing a new generation of advanced nonlinear electro-optic and all-optical organic polymers that can convert high-speed electronic signals into optical signals or allow light waves to switch other light waves.
Linkam develops and manufactures a broad range of heating and freezing stages for both OEM and end users to visualize and explore materials properties. Used in conjunction with light microscopes and other forms of spectroscopy, Linkam stages are found in thousands of laboratories worldwide with the most successful heating/freezing stage, the THMS600, selling over 3000 units alone.
The combination of a protected blood transporting nanocarrier system and a tumor specific activation technology makes LiPlasome Pharma very competitive in a commercially attractive and dynamic anticancer market, where drug delivery systems will gain increasing importance over the coming years.
Living Cell is developing cell-based products to treat life threatening human diseases. The company has developed proprietary nanobiocapsules which allow encapsulated pig insulin producing cells, DiabeCell, to be implanted without the use of toxic immune suppressive drugs.
London Graphene Ltd was established in 2013 to develop advanced energy storage applications based on high quality graphene. The company has an option on some patents from the Department of Materials at the University of Oxford on CVD graphene.